Cline Christopher R. bought TVTX

September 15, 2026 · Form 4 insider transaction

Cline Christopher R. bought 20,000 shares of Travere Therapeutics, Inc. at $17.44 per share, a transaction worth $348.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.